Nazli Rahim's practice includes the preparation and prosecution of domestic and foreign patent applications in the fields of biotechnology, immunology, oncology, cell biology, and pharmaceuticals. She also has experience in conducting IP due diligence evaluations, patentability analysis, and freedom to operate analysis.
Nazli has drafted and prosecuted patent applications directed to CRISPR gene editing, antibody therapeutics, enzyme replacement therapies, CAR-T cell therapies, drug formulations, cancer therapeutics, and next-generation sequencing.
Prior to joining Jones Day, Nazli obtained her Ph.D. in genetics at Caltech, where she studied the molecular mechanisms underlying proteolysis. She has more than 10 years of industry experience and has conducted research at the European Molecular Biology Laboratory, the Cancer Research Center of Lyon, The Scripps Research Institute, and Genentech.
- Santa Clara University (currently attending law school with expected graduation in 2022); California Institute of Technology (Ph.D. in Genetics, 2007); University of California, Berkeley (B.A. in Biochemistry and Molecular Biology 1996)
- Registered to practice before the United States Patent and Trademark Office. Not licensed to practice by the State Bar of California.